Falência da extubação orotraqueal em uma amostra de pacientes oncológicos by Agu, Camilla Giovana et al.
Rev Med (São Paulo). 2020 Nov-Dec;99(6):545-55.
545
doi: http://dx.doi.org/10.11606/issn.1679-9836.v99i6p545-555
Rate of orotracheal extubation failure in a sample of cancer patients 
Falência da extubação orotraqueal em uma amostra de pacientes oncológicos
Camilla Giovanna Agu1, Pedro Caruso2, Indiara Soares de Oliveira1,  
Celena Freire Friedrich1, Ivan Peres Costa3
Agu CG, Caruso P, Oliveira IS, Friedrich CF, Costa IP. Rate of orotracheal extubation failure in a sample of cancer patients / Falência 
da extubação orotraqueal em uma amostra de pacientes oncológicos. Rev Med (São Paulo). 2020 Nov-Dec;99(6):545-55.
Institution where the work was carried out: AC Camargo Cancer Center, Department of Physiotherapy.
Presented at the European Respiratory Society International Congress, Paris, France, September 15-19, 2018.
1. Department of Physiotherapy AC Camargo Cancer Center (AC Camargo) - São Paulo, Brazil. ORCID: Agu CG - https://orcid.org/0000-0001-7866-
2379; Oliveira IS - https://orcid.org/0000-0002-6045-1765; Friedrich CF - https://orcid.org/0000-0002-6361-0258. E-mails: camilla.agu@gmail.com, 
indiara.doc@gmail.com, celenafriedrich@yahoo.com.br.
2. Intensive Care Unit AC Camargo Cancer Center (AC Camargo) - São Paulo, Brazil. Pulmonary Division, Instituto do Coração (InCor) do Hospital 
das Clínicas, School of Medicine, Universidade de São Paulo. https://orcid.org/0000-0002-1051-8458. E-mail: pedcaruso@gmail.com.
3. Professor of Physiotherapy and Medicine Guarulhos degree’s at University Nove de Julho (UNINOVE) - São Paulo, Brazil. https://orcid.org/0000-
0002-8566-7976. E-mail: yvanperes@gmail.com.
Correspondence: Rua Itapiru, 224, apto 21 , Saúde - São Paulo, SP, Brazil. Zip Code: 04142-010. E-mail: yvanperes@gmail.com.
ABSTRACT: Objective: To classify the rate of orotracheal 
extubation failure (EF) in a sample of cancer patients and to 
evaluate the association between FE, mortality index and clinical 
events. Methods: A retrospective descriptive study was carried 
out to collect data from the medical records from March 2012 
to May 2017 involving 1,088 medical records that required 
invasive ventilatory support during ICU admission. Results: 39 
patients required early reintubation during ICU stay, in which 
the EF incidence rate was 3.6%, mean age 59.6 years, with a 
predominance of males, with a high incidence of respiratory 
complications and pneumonia. The mean reintubation time after 
extubation was 16.5 ± 14.0 h, with respiratory fatigue (48.7%) 
being the main reason for reintubation, and the main outcome 
was death (56.4%). Three univariate and multivariate regression 
models were used for the reintubation time, days of ICU stay (R2: 
61.7%) and death (R2: 78.8), which demonstrated independent 
variables capable of predicting change in the models studied. The 
model that best responded to our goal was death with explained 
variance of 78.8%. Conclusion: Our findings demonstrated a low 
incidence of extubation failure and the importance of identifying 
specific risk factors for the cancer population, predicting that such 
factors could influence the need for reintubation.
Keywords: Physiotherapy; Extubation; Intensive care; Oncology; 
Intensive care units; Weaning; Intubation.
RESUMO: Objetivo: Classificar a taxa de falha de extubação 
orotraqueal (FE) em uma amostra de pacientes oncológicos e 
avaliar a associação entre FE, índice de mortalidade e eventos 
clínicos. Métodos: Estudo descritivo, retrospectivo, para coleta 
de dados do prontuário no período de março de 2012 a maio de 
2017 envolvendo 1.088 prontuários que necessitaram suporte 
ventilatório invasivo durante a internação na UTI. Resultados: 39 
pacientes necessitaram de reintubação precoce durante a estadia 
em UTI, no qual a taxa de incidência de FE  foi de 3,6%, média 
de idade de 59,6 anos com predomínio do sexo masculino, com 
uma alta incidência de complicações respiratórias e pneumonia. 
O tempo médio de reintubação após a extubação foi de 16,5 
± 14,0 h, tendo como principal motivo da reintubação fadiga 
respiratória (48,7%) e o principal desfecho foi óbito (56,4%). 
Foram elaborados três modelos de regressão univariada e 
multivariada para o tempo de reintubação, dias de internação na 
UTI (R2: 61,7%) e o óbito (R2: 78,8) que demonstrou variáveis 
independentes capazes de predizer a mudança nos modelos 
estudados. O modelo que melhor respondeu à nossa meta foi óbito 
com variância explicada de 78,8%. Conclusão: Nossos achados 
demonstraram uma baixa incidência da falência na extubação e a 
importância da identificação de fatores de risco específicos para 
a população oncológica, predizendo que tais fatores poderiam 
influenciar a necessidade de reintubação.
Palavras-chave: Fisioterapia; Extubação; Terapia intensiva; 
Oncologia; Unidades de terapia intensiva; Desmame; Intubação
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INTRODUCTION
Mechanical ventilation (MV) is a method of ventilatory support that involves either partial 
or total replacement of spontaneous ventilation. Positive 
pressure facilitates the delivery of oxygen to the lungs by 
equipment such as artificial mechanical ventilators. The 
aim of MV is to maintain adequate gas exchange, relieve 
the respiratory muscles, allow specific interventions, and 
reduce lung injury1,2 .
The indications for MV include respiratory failure, 
inadequate blood oxygen and carbon dioxide levels, 
cardiorespiratory arrest, respiratory muscle weakness, or 
unstable breathing commands1.
Intensive care units (ICUs) specific to patients 
with cancer may have particular requirements because 
the therapies used to treat neoplasia can cause clinical 
complications, side effects, compromised organic functions, 
and general weakness; in some cases, patients with cancer 
require MV, which is therefore a routine procedure in 
ICUs3,4.(
If a patient no longer requires MV within 48 hours 
of extubation, their weaning from MV is considered 
successful. Intolerance to the spontaneous breathing test 
(SBT) after extubation is defined as weaning failure2. In 
most patients, MV weaning occurs successfully, but some 
have extubation failure (EF) and require reintubation 
after 24–72 hours5. Specifically, EF occurs in 30%–40% 
of patients6 and is associated with prolonged stay in ICUs 
and hospitals, as well as higher rates of tracheostomy and 
mortality7-10.
There are some requirements for initiating weaning, 
such as a favorable clinical status, resolution or stabilization 
of the underlying disease, hemodynamic stability, and the 
ability to breathe spontaneously. As such, before weaning 
is initiated, weaning predictive indexes are applied2.
Several researchers have suggested that EF is 
associated with a high mortality rate, although this remains 
unclear. Moreover, although some studies have evaluated 
failure of orotracheal extubation and its correlation with 
mortality5,6,11-13, little is known about EF in cancer patients14. 
For this reason, a data survey must be conducted to assess 
whether the need for reintubation is an important predictor 
of prognosis and mortality rate.
OBJECTIVES
To assess the failure rate of orotracheal extubation 
in a sample of patients with cancer from a teaching hospital 
in São Paulo, as well as to ascertain the main clinical 
outcomes in patients who required reintubation, the present 
study aimed to evaluate whether EF was associated with 
mortality rate or clinical events.
METHODOLOGY
Study Design
This was a descriptive, retrospective study, which 
was carried out by reviewing the clinical history and 
analyzing the medical records of patients who required 
early intubation at the ICU of AC Camargo, which is a 
teaching hospital specializing in cancer treatment located 
in the city of São Paulo. The hospital has 55 adult ICU 
beds. We collected demographic data (sex, age, weight, 
and height), cancer diagnosis, comorbidities, reason 
for admission to the ICU, date of intubation, reason for 
intubation, success on the SBT, date of extubation, date 
of reintubation, reason for reintubation, use of non-
invasive ventilation (NIV) after extubation, sedative drugs, 
vasoactive drugs, chemotherapy during the orotracheal 
intubation (OI) period, complications after reintubation 
(pulmonary, cardiovascular, and neurological), and 
outcomes after early reintubation. 
Sample
All patients who required reintubation during their 
ICU stay between March 2012 and December 2017 were 
included. All data were collected from patients’ electronic 
medical records and entered into a digitalized electronic 
spreadsheet (Excel®, Microsoft Office). The study was 
approved by the Research Ethics Committee (Protocol 
1.849.306), and informed consent was not required for 
data analysis.
Exclusion criteria
The following exclusion criteria were applied: age 
< 18 years, medical records that did not mention the need 
for reintubation, insufficient data, OI period of < 48 hours.
Statistical analysis
The variables of interest collected were inserted 
into a digitalized electronic spreadsheet (Excel) and 
standardized. They were then statistically analyzed using 
the Statistical Package for Social Sciences (SPSS) version 
20.0.
A descriptive analysis was performed to determine 
the characteristics of the study population, with categorical 
variables presented as absolute numbers and percentages. 
Continuous variables that showed normal distribution were 
expressed as mean and standard deviation, whereas those 
that did not show normal distribution were expressed as 
median and interquartile range.
Both univariate and multivariate regression models 
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were incorporated to verify whether the independent 
variables were associated with the dependent variables. 
The independent variables were as follows: sex, age, body 
mass index, comorbidities, cancer diagnosis, reason for 
admission to the ICU, presence of infections upon admission 
to the ICU, location of such infections, reason for initial 
OI, reason for early reintubation, complications, surgical 
approaches during the ICU stay, use of chemotherapy, 
vasoactive and antiarrhythmic drugs, outcome after early 
reintubation, such as the use of NIV after extubation and 
the need for tracheostomy, while the dependent variables 
were as follows: time of reintubation, length of ICU stay 
in days, and death.
Categorical variables were coded as dummy 
variables. In the sequence, all variables that showed a 
p-value ≤ 0.20 in the univariate linear regression analysis 
were included in the multivariate regression model. 
The multivariate regression analysis used the backward 
elimination method, which was considered complete when 
all variables reached a p-value < 0.05. The assumptions of 
linearity and multicollinearity were not violated in either 
model. 
RESULTS
We analyzed the medical records of 1088 patients 
who underwent OI and remained for more than 48 hours 
on invasive ventilatory support between March 2012 
and Dec 2017. Of these, 1049 patients were excluded for 
specific reasons, as shown in the flowchart in Figure 1. 
The final sample thus consisted of 39 (3.6%) patients who 
underwent failed extubation during their stay in the ICU 
and required reintubation within 48 hours. Table 1 shows 
the anthropometric and clinical characteristics of the study 
population.
Subtitle:  ARF: Acute respiratory failure; n: number of patients; ICU: Intensive care unit; MODS: Multiple Organ Dysfunction Syndrome; NIV: Non-
-invasive ventilation; UTI: Urinary tract infection; VAP: Ventilator-associated pneumonia. Values are expressed as a percentage
Figure 1: Study of flowchart
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Table 1. General characteristics of patients
Variables n = 39
Age 59.5 ± 13.3
Sex 
Female  14 ± 35.9
Male 25 ± 64.1
BMI 26.1 ± 5.1
ECOG 1.47 ± 1.19







Smoker / ex-smoker 21 (53.8)
Alcoholic / ex-alcoholic 4 (10.3)
Diagnosis of ICU admission, n (%)
Postoperative monitoring 5 (12.8)
Lower-level consciousness 5 (12.8)
Hypovolemic or hemorrhagic shock 2 (5.1)
ARF 11 (28.2)
Sepsis, Septic shock 11 (2.8)
Arrhythmia 2 (5.1)
Agitation, state of mental confusion 2 (5.1)
Other 1 (2.6)
Clinical or Surgical Patient, n (%)
Clinical 32 (82.1)
Surgical 7 (17.9)
Hematological or Solid Tumor, n (%)
Hematological 6 (15.4)
Solid 33 (84.6)
Disease progression 22 (56.4)
In cancer treatment 30 (76.9)
Chemotherapy treatment 29 (74.4)
ICU Surgical Approaches 26 (66.7)
Use of Vasoactive Drugs 34 (87.2)
Use of Antiarrhythmic Drugs 12 (30.8)
State of mental confusion 33 (84.6)
Reintubation time (hours) 16.5 ± 14.0
Length of ICU stay (days) 22.4 ± 13.5
Subtitle: ARF: Acute respiratory failure; BMI: body mass index; ECOG: 
Eastern Cooperative Oncology Group; ICU: Intensive care unit; n: number 
of patients. 
Categorical variables are expressed as absolute numbers and percentages 
(%) and continuous variables are expressed as mean ± standard deviation; 
median (interquartile range) *.
Reintubation time
The patients were reintubated at an average of 
16.5 ± 14.0 hours after extubation. Table 2 presents the 
results of the univariate and multivariate regression models 
for reintubation time. The final equation to predict the 
intubation time, derived from the multivariate model, was 
as follows: 
Reintubation time = 11.08 + (0.32 × CT treatment) 
+ (-0.38 × self-extubation or accidental extubation). 
A value of 1 was assigned if patients were 
undergoing chemotherapy or if they showed self-
extubation or accidental extubation. Patients with none 
of these criteria were given a value of 0. For example, 
comparing a patient who underwent OI with a patient 
who did not undergo chemotherapy, both of whom had 
self-extubation/extubation-accidental, the difference in 
reintubation time was only 0.31 hours (18 minutes).
Days in ICU
The patients stayed a mean of 22.4 ± 13.5 days in 
the ICU. Table 3 presents the results of the univariate and 
multivariate regression models analyzing the length of 
the ICU stay in days. The final equation derived from the 
multivariate model to predict the number of hospitalization 
days was as follows:
Days in ICU = 34.23 + (-0.42 × sex) + (0.27 × 
fatigue) + (-0.25 × self-extubation or accidental extubation) 
+ (0.46 × tracheostomy)
A sex value of 1 was assigned to females while 2 
was assigned to males; similarly, a value of 1 was assigned 
for the events, while 0 was assigned when no events 
took place. For example, a female patient who suffered 
reintubation due to fatigue and her outcome was submitted 
to tracheostomy compared to a male patient who suffered 
reintubation for the same reason and with the same outcome 
the difference was only 0.42 days of hospitalization in ICU.
Death
Of the patients included in the present study, an 
average of 54.6% died as the final outcome. Table 4 shows 
the results of univariate and multivariate regression models 
for death. The final equations derived from the multivariate 
model to predict death after reintubation are as follows:
Surgical patient= 0.17 + (0.26 × ECOG) + (-0.60 
× surgical patient) + (0.63 chemotherapy treatment) 
+ (0.32 × postoperative monitoring) + (0.39 × use 
of vasoactive drugs).
Death
Clinical Patient= 0.17 + (0.26 x ECOG) + (-0.60 × 
clinical patient) + (0.63 chemotherapy treatment) + 
(0.32 × hypovolemic or hemorrhagic shock) + (0.39 
× use of vasoactive drugs).
By performing a comparison of a surgical patient 
or a clinical patient who underwent an assessment of the 
impact of the disease on their daily activities using the 
Eastern Cooperative Oncology Group (ECOG) scale, we 
obtained a score of 1 (one) on the scale and another who 
obtained a value of 4; considering the other variables of 
both patients a value of 1, the difference between them 
was 0.24, that is, on a scale between 0 and 1, these patients 
would evolve with a 0.24 probability of the outcome of 
death.
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Table 2. Univariate and Multivariate regression analysis for the Reintubation time
Univariate Regression Multivariate Regression
     R2: 23,5% F: 5,07 Constancy: 11,087
Independent variables Beta (IC to 95%) p R2 (%)    F Beta (IC95%) p
Age -0,262 (- 0,653 a 0,081) 0,122* 0,069 2,511
Sex -0,003 (-10,256 a 10,555) 0,984 0 0
BMI -0,012 (- 1,049 a 0,977) 0,942 0 0,005
ECOG -0,053 (- 4,460 a 3,408) 0,786 0,003 0,075
Comorbidities -0,174 (- 25,692 a 8,424) 0,311 0,03 1,058
Clinical or Surgical Patient  0,340 (0,450 a 24,611) 0,042* 0,116 4,443
Hematological Tumor -0,088 (-17,295 a 10,283) 0,609 0,008 0,267
Solid Tumor  0,088 (-10,283 a 17,295) 0,609 0,008 0,267
Disease progression  0,168 (- 4,833 a 14,074) 0,328 0,028 0,987
In cancer treatment -0,034 (-12,644 a 10,373) 0,842 0,001 0,04
Chemotherapy treatment  0,299 (-1,079 a 20,024) 0,077* 0,089 3,328 0,316 (0,200 a 19,871) 0,046**
Diagnosis of ICU admission
Postoperative monitoring  0,314 (-0,730 a 28,194) 0,062* 0,099 3,723
Lower-level consciousness -0,051 (-15,841 a 11,810) 0,769 0,003 0,088
Hypovolemic or hemorrhagic shock -0,214 (-33,256 a 7,575) 0,210* 0,046 1,634
ARF  0,065 (-8,432 a 12,309) 0,706 0,004 0,144
Sepsis, Septic shock  0,013 (-10,275 a 11,100) 0,938 0 0,006
Arrhythmia -0,121 (-27,985 a 13,510) 0,483 0,015 0,503
Agitation, state of mental confusion -0,105 (-37,717 a 20,227) 0,544 0,011 0,376
Others -0,142 (-40,670 a 17,008) 0,410 0,02 0,695
Infection at ICU admission -0,066 (-14,372 a 9,767) 0,701 0,004 0,15
ICU Surgical Approaches -0,028 (-10,752 a 9,174/) 0,873 0,001 0,026
Use of Vasoactive Drugs -0,007 (-14,111 a 13,575) 0,969 0 0,002
Use of Antiarrhythmic Drugs -0,104 (-13,449 a 7,224) 0,545 0,011 0,374
State of mental confusion  0,110 (-19,966 a 10,315) 0,522 0,012 0,42
Reason for Reintubation
Upper airway obstruction
Lower-level consciousness -0,043 (-12,395 a 9,697) 0,806 0,002 0,062
Hemodynamic instability  0,060 (-11,440 a 16,196) 0,729 0,004 0,122
Inability to deal with secretions  -0,023 (-10,455 a 9,181) 0,896 0,001 0,017
Hypoxemia  0,054 (-8,561 a 11,721) 0,753 0,003 0,1
Cardiorespiratory arrest
Fatigue  0,303 (-0,813 a 17,467) 0,073* 0,092 3,428
ARF  0,008 (-20,417 a 21,382) 0,963 0 0,002
Procedure  0,152 (-11,573 a 29,745) 0,378 0,023 0,799
Others -0,037 (-13,362 a 10,814) 0,832 0,001 0,046
Self-extubation/Accidental extubation -0,368 (-27,488 a -1,744) 0,027* 0,135 5,325 -0,383 (-27,513 a -2,883) 0,017**
Outcome
NIV postextubation  0,270 (-1,970 a 17,053) 0,116* 0,073 2,602
Tracheostomy -0,135 (-13,290 a 5,801) 0,431 0,018 0,636    
Subtitle: ARF: Acute respiratory failure; BMI: body mass index; ECOG: Eastern Cooperative Oncology Group; ICU: Intensive care unit; NIV: Non-invasive ventilation
Univariate regression: values of p≤ 0.20; Multivariate regression: ** statistically significant values
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Table 3: Univariate and Multivariate regression analysis for ICU admission days
Subtitle: ARF: Acute respiratory failure; BMI: body mass index; ECOG: Eastern Cooperative Oncology Group; ICU: Intensive care unit; NIV: Non-invasive ventilation
Univariate regression: values of p≤ 0.20; Multivariate regression: ** statistically significant values.
Univariate Regression Multivariate Regression
 R2: 61,7% F: 13,670 Constancy: 34,228
Independent variables Beta (IC to 95%) p R
2 
(%) F Beta (IC95% p
Age -0,150 (-0,487 a 0,182) 0,362 0,022 0,851
Sex -0,486 (-21,708 a -5,457) 0,002* 0,237 11,472 -0,425 (-18,051 a -5,665) 0,000**
BMI 0,106 (-0,600 a 1,161) 0,522 0,011 0,417
ECOG -0,241 (-6,877 a 1,373) 0,183* 0,058 1,856
Comorbidities -0,109 (-19,425 a 9,810) 0,509 0,012 0,444
Clinical or Surgical Patient 0,224 (-3,503 a 19,155) 0,170* 0,05 1,959
Hematological Tumor 0,087 (-9,091 a 15,545) 0,599 0,008 0,282
Solid Tumor -0,087 (-15,545 a 9,091) 0,599 0,008 0,282
Disease progression -0,172 (-13,512 a 4,213) 0,295 0,03 1,13
In cancer treatment 0,045 (-9,145 a 12,011) 0,785 0,002 0,075
Chemotherapy treatment 0,107 (-6,883 a 13,434) 0,518 0,011 0,427
Diagnosis of ICU admission
Postoperative monitoring 0,091 (-9,660 a 16,919) 0,583 0,008 0,306
Lower-level consciousness -0,041 (-14,980 a 11,686) 0,804 0,002 0,063
Hypovolemic or hemorrhagic shock -0,242 (-34,314 a 4,936) 0,138* 0,059 2,3
ARF -0,020 (-10,519 a 9,305) 0,902 0 0,015
Sepsis, Septic shock 0,031 (-8,997 a 10,822) 0,853 0,001 0,035
Arrhythmia -0,034 (-22,255 a 18,174) 0,839 0,001 0,042
Agitation, state of mental confusion 0,175 (-9,307 a 30,523) 0,287 0,031 1,165
Others 0,007 (-27,645 a 28,803) 0,967 0 0,002
Infection at ICU admission -0,315 (-20,944 a 0,025) 0,051* 0,099 4,086
ICU Surgical Approaches 0,405 (-2,846 a 20,154) 0,011* 0,164 7,25
Use of Vasoactive Drugs 0,196 (-5,245 a 20,927) 0,232 0,038 1,474
Use of Antiarrhythmic Drugs 0,032 (-8,726 a 10,596) 0,846 0,001 0,038
State of mental confusion 0,014 (-11,849 a 12,879) 0,933 0 0,007
Reason for Reintubation
Upper airway obstruction
Lower-level consciousness -0,163 (-15,636 a 5,258) 0,321 0,027 1,013
Hemodynamic instability -0,173 (-20,067 a 6,220) 0,293 0,03 1,139
Inability to deal with secretions             -0,022 (-9,768 a 8,568) 0,895 0 0,018
Hypoxemia 0,443 (4,185 a 21,518) 0,005* 0,196 9,028
Cardiorespiratory arrest
Fatigue 0,286 (-0,884 a 16,221) 0,077* 0,082 3,301 0,272 (1,457 a 13,141) 0,016**
ARF -0,129 (-27,895 a 12,219) 0,434 0,017 0,627
Procedure -0,088 (-21,121 a 12,232) 0,592 0,008 0,292
Others -0,225 (-19,172 a 3,484) 0,169* 0,051 1,968
Self-extubation/Accidental extubation -0,270 (-23,672 a 2,025) 0,096* 0,073 2,914 -0,253 (-18,812 a -1,469) 0,023**
Outcome
NIV postextubation -0,018 (-9,660 a 8,685) 0,915 0 0,012
Tracheostomy 0,574 (8,126 a 22,864) 0,000* 0,329 18,151 0,460 (6,428 a 18,396) 0,000**
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Table 4: Univariate and Multivariate Regression Analysis for death
Univariate Regression Multivariate Regression
     R2: 78,8% F: 15,531 Constancy: 0,166
Independent variables Beta (IC to 95%) p R
2 
(%) F Beta (IC95%) p
Age -0,104 (-0,016 a 0,009) 0,531 0,011 0,401
Sex -0,011 (-0,356 a 0,333) 0,947 0 0,005
BMI  0,012 (-0,032 a 0,034) 0,944 0 0,005
ECOG  0,514 (0,082 a 0,353) 0,003* 0,264 10,766  0,265 (0,023 a 0,201) 0,016**
Comorbidities  0,044 (0,472 a 0,615) 0,792 0,002 0,071
Clinical or Surgical Patient -0,532 (-1,052 a - 0,323) 0,000* 0,283 14,61 -0,599 (-1,175 a 0,348) 0,001**
Hematological Tumor  0,375 (0,091 a 0,940) 0,019* 0,14 6,048
Solid Tumor -0,375 (-0,940 a -0,091) 0,019* 0,14 6,048
Disease progression  0,270 (-0,051 a 0,591) 0,096* 0,073 2,911
In cancer treatment -0,113 (-0,523 a 0,256) 0,492 0,013 0,481
Chemotherapy treatment  0,431 (0,148 a 0,831) 0,006* 0,186 8,45  0,629 (0,465 a 0,976) 0,000**
Diagnosis of ICU admission
Postoperative monitoring -0,436 (-1,092 a -0,202) 0,005* 0,19 8,697  0,318 (-0,013 a 0,968) 0,056**
Lower-level consciousness  0,028 (-0,453 a 0,535) 0,867 0,001 0,029
Hypovolemic or hemorrhagic shock  0,204 (-0,274 a 1,193) 0,212* 0,042 1,613  0,317 (0,328 a 1,478) 0,003**
ARF  0,091 (-0,265 a 0,466) 0,58 0,008 0,311
Sepsis, Septic shock -0,024 (-0,393 a 0,341) 0,887 0,001 0,021
Arrhythmia -0,030 (-0,816 a 0,681) 0,856 0,001 0,033
Agitation, state of mental confusion  0,204 (-0,274 a 1,193) 0,212* 0,042 1,613
Others  0,143 (-0,587 a 1,482) 0,386 0,02 0,768
Infection at ICU admission  0,322 (0,008 a 0,782) 0,046* 0,104 4,274
ICU Surgical Approaches -0,183 (-0,537 a 0,152) 0,265 0,033 1,279
Use of Vasoactive Drugs  0,282 (-0,056 a 0,892) 0,082* 0,079 3,186  0,387 (0,281 a 0,880) 0,001**
Use of Antiarrhythmic Drugs  0,138 (-0,206 a 0,503) 0,403 0,019 0,717
State of mental confusion -0,088 (-0,577 a 0,335) 0,593 0,008 0,29
Reason for Reintubation
Upper airway obstruction
Lower-level consciousness  0,236 (-0,103 a 0,659) 0,148* 0,056 2,183
Hemodynamic instability  0,028 (-0,453 a 0,535) 0,867 0,001 0,029
Inability to deal with secretions              0,057 (-0,281 a 0,397) 0,729 0,003 0,122
Hypoxemia -0,198 (-0,564 a 0,138) 0,226 0,039 1,513
Cardiorespiratory arrest
Fatigue  0,029 (-0,301 a 0,359) 0,86 0,001 0,032
ARF -0,030 (-0,816 a 0,681) 0,856 0,001 0,033
Procedure  0,060 (-0,508 a 0,730) 0,718 0,004 0,132
Others  0,007 (-0,421 a 0,439) 0,967 0 0,002
Self-extubation/Accidental extubation  0,182 (-0,215 a 0,756) 0,266 0,033 1,274
Outcome
NIV postextubation  0,017 (0,102 a 0,920) 0,92 0 0,01
Tracheostomy -0,166 (-0,494 a 0,163) 0,313 0,027 1,046    
Subtitle: ARF: Acute respiratory failure; BMI: body mass index; ECOG: Eastern Cooperative Oncology Group; ICU: Intensive care unit; NIV: Non-invasive ventilation. Univariate regression: values of 
p≤ 0.20; Multivariate regression: ** statistically significant values.
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DISCUSSION
The use of MV and EF are associated with a 
prolonged ICU stay and are important predictive factors 
of prognosis and mortality. Therefore, it is important that 
interdisciplinary teams treating patients with cancer who 
undergo MV identify these factors. The present study 
involved patients with cancer who underwent reintubation 
within a 48-hour period. Most patients a comorbidity, 
the most prevalent of which was cardiovascular disease 
(59%). The prevalence of admission to the ICU was greater 
in clinical patients (82.1%) who were hospitalized for 
respiratory failure, followed by postoperative monitoring 
and lower-level consciousness (28%). After conducting the 
study and comparing it with the bibliography, we identified 
variables of interest to be verified and hypothesized that 
patients with cancer have specific and unique risk factors 
for EF.
Chemotherapy data were collected in the present 
study, with most of the population studied undergoing 
chemotherapy (74.4%). The most prevalent chemotherapy 
drugs were carboplatin (23.1%), paclitaxel (20.5%), 
5-fluorouracil (15.4%), cisplatin (15.4%), etoposide 
(15.4%), and docetaxel (Taxotere; 10.3%). We found 
no studies that assessed whether EF was associated 
with chemotherapy. In addition, patients were treated 
using different chemotherapy protocols, and the cancer 
population was heterogeneous, although solid tumors were 
predominant (84.6%).
Retrospective studies15–17 have evaluated different 
populations presenting with EF, dividing them into 
two groups: patients successfully extubated and those 
who presented EF. In a study by Li et al.17, the studied 
population was reintubated because of airway obstruction 
after previous cervical surgery. Nantsupawat et al.16 studied 
patients with chronic obstructive disease (COPD) who were 
reintubated due to respiratory failure. Finally, the study by 
Brown et al.15 evaluated patients who suffered trauma and 
were admitted to the ICU requiring MV.
In previous, prospective studies6,13, the impact 
of EF on the general population has been assessed. 
Thille et al.13 compared patients undergoing planned 
and unplanned extubation. In a study by Epstein et al.6, 
patients were allocated into two groups: surviving and 
non-surviving patients. These authors identified mortality 
associated with reintubation time and categorized patients 
according to the causes of EF, as follows: airway etiology 
(obstruction, aspiration, excess pulmonary secretions) 
and extrapulmonary etiology (congestive heart failure, 
encephalopathy, etc.).
Among the studies described, the populations that 
presented EF had an average age between 55 and 65 years, 
with a predominance of males, corroborating our findings. 
In addition, patients who smoked were predominant at 
71.42%17. In our study, 53.8% of the patients were smokers 
or ex-smokers, and 84.6% had altered mental status 
occurred while in the ICU. This was much higher than in 
the study by Brown et al.15, in which 47% of patients in 
ICU showed altered mental status.
In their study, Brown et al.15 found pulmonary 
infections to be the most prevalent complication (35%), 
corroborating our findings, in which the most prevalent 
complication was of respiratory origin (61.5%). In addition, 
in the study by Thille et al.13, 27% of patients with EF 
developed pneumonia; in the present study, we found an 
infection rate of 79.5% upon admission to the ICU, with 
the most prevalent being pneumonia (41%). 
In the literature6,13, the requirement for reintubation 
is considered EF, even after more than 72 hours. In contrast, 
the present study, considered EF as the requirement for 
reintubation after more than 48 hours. In previous studies, 
EF rates have varied between 1.81% and 19%3,13,17; these 
values differ according to the population studied and 
the time of OI. In the study by Santos et al.3, the authors 
investigated a heterogeneous cancer population and found 
high EF values (17.5%); these results that differ from the 
present study, in which occurred in only 3.6% of patients, 
even though the population was similar. In addition, the 
study by Thille et al.13 found that patients undergoing 
unplanned extubation had a higher incidence of EF (65%).
Although several hypotheses have been suggested, 
it is not yet clear whether EF is associated with high 
mortality rates. Studies6,18 have reported that the act of 
reintubation itself results in complications, and that clinical 
deterioration occurs during the time without ventilatory 
support between extubation and reintubation. Studies have 
found high rates of hospital mortality4,18–22 in patients with 
cancer who required ventilatory support, ranging from 
50% to 83%.
Raymond et al.14 analyzed the predictors of 
morbidity and mortality after resection of esophageal 
cancer and observed that mortality rates (12.2%) were 
related to various events, including reintubation. In the 
present study, we found a significantly high mortality 
rate of 54.8%. In the study by Thille et al.13 in the general 
population and by Nantsupawat et al.16 among patients 
diagnosed with COPD, about 50% of patients died after 
reintubation, which corroborates our findings.
Previous authors6,15 have reported that the average 
length of stay in the ICU after reintubation was between 
15 and 21 hours. In the present study, we found an average 
reintubation time of 16.5 hours. Nantsupawat et al.16 
reported that the ICU stay was three times longer in patients 
with EF than in those who underwent successful extubation 
(mean of 14 days). In our study, we found a higher average, 
with 22.44 days of hospitalization. Previous studies22,23 have 
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also verified the effectiveness of early-use, non-invasive 
MV immediately after extubation. In the present study, 
prophylactic NIV reduced reintubation rates and mortality 
in patients at high risk for EF. Moreover, the use of NIV 
was instituted in approximately 43.6% of the population 
to avoid early reintubation.
The reasons for reintubation found in a study by 
Epstein et al.6 showed a higher incidence of EF prompted 
by extrapulmonary etiologies than the present study, which 
found a higher incidence of EF prompted by fatigue, 
inability to deal with secretions, and hypoxemia. The 
reasons for reintubation in the study by Brown et al.15 
included respiratory failure (76%) and accumulation of 
secretions (18%), which is consistent with our findings.
Some studies in the literature6,15,16 performed 
univariate and multivariate regression models, which 
were used in the present study. Epstein et al.6 found 
that the reason for EF and the time to reintubation 
were independently associated with hospital mortality. 
They concluded that the etiology of EF and the time to 
reintubation were independent predictors of outcome in 
the study population. Similarly, in the study by Brown 
et al.15, the risk of reintubation did not depend on factors 
that affected EF in the study population, which included 
fracture of the spine and airway as an indication for initial 
intubation, as well as delirium and lower Glasgow Coma 
Scale (GCS) score during extubation; however, there was 
no difference in mortality between the groups studied. 
Nantsupawat et al.16 demonstrated that reintubation was 
significantly associated with sedative and analgesic drugs 
administered before extubation, with reintubation being 
more frequent in patients with acute exacerbations of 
COPD.
It was not possible to compare all significant 
variables found in previous studies that performed 
regression analysis and test the confidence of the models 
because some studies reported too few details of their 
analysis, while others used different dependent variables, 
independent variables, and objectives from the present 
study.
Regarding the regression analysis carried out in 
the present study, all variables included in the univariate 
models (p < 0.20) could predict some changes in the models 
studied: time of reintubation, days in the ICU, and death; 
however, after the analysis of multivariate variables, we 
found unique variables that predicted changes.
Thus, after multivariate analysis, the only variables 
that could predict change in reintubation time were 
treatment with chemotherapy (β = 0.32) and self-/accidental 
extubation (β: - 0.38), presenting an explained variance of 
only 23.5%. In the hospitalization days model, we found 
that sex (β: 0.42), reintubation due to fatigue (β: 0.27), 
reason due to self-/accidental extubation (β: -0.25), and 
tracheostomy outcome (β: 0.46) had an explained variance 
of 61.7%.
Finally, in the death model, ECOG score (β: 0.26), 
type of patient (clinical or surgical) (β: -0.60), treatment 
with chemotherapy (β: 0.63), ICU admission based on 
postoperative monitoring (β: 0.32), ICU admission based 
on hypovolemic or hemorrhagic shock (β: 0.32), and 
surgical approaches in ICU (β: 0.39) had an explained 
variance of 78.8%.
Another important finding after multivariate 
regression analysis, with statistically significant death as 
the dependent variable, was that the scale for assessing the 
impact of the disease on daily activities (ECOG; p < 0.01), 
had a β-value of 0.26. In addition, this analysis showed 
that, each year a patient lives, 0.2 points would be added 
to their ECOG scale, and higher ECOG scores indicated 
greater possibility of death. Other significant variables were 
treatment with chemotherapy (p < 0.00), type of clinical or 
surgical patient (p < 0.00), surgical approach during ICU 
stay (p < 0.00), diagnosis prompting ICU admission (p < 
0.05), and hypovolemic shock (p < 0.00). However, it is 
impossible to measure the clinical significance of each of 
these variables.
Comparing the three models, the models that best 
answered our objective were those that considered whether 
length of ICU stay and death were associated with EF, with 
an explained variance of 61.7% and 78.8%, respectively. 
Thus, the most reliable model is composed of the dependent 
variable death, which is closest to the R2 value of 100%.
The present study had some limitations. Firstly, 
none of the measures or data collections were related to 
the spontaneous breathe test (SBT)24, maximum respiratory 
pressure test, or MV time preceding extubation, which 
are important data in intensive care clinical practice 
because they inform the protocols for discontinuing MV. 
Furthermore, the patients’ medical records contained 
insufficient data to classify the Sequential Organ Failure 
Assessment (SOFA) or Acute Physiology and Chronic 
Health Evaluation (APACHE) score. These systems use 
physiological data, information related to the patient’s 
disease, and conditions to predict the likelihood of death. 
Such models can facilitate risk stratification in the context 
of intensive care.
CONCLUSION
The incidence of EF in the studied cancer population 
was low (3.6%), and EF was associated with more clinical 
events involving respiratory complications and pneumonia. 
Fatigue was the main reason for reintubation, and death was 
the main outcome. Therefore, to avoid EF, clinicians must 
identify specific risk factors that can influence the need for 
reintubation in the oncology population.
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